SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (47856)12/14/2017 4:11:25 PM
From: J_F_Shepard  Read Replies (1) of 362069
 
fyi....excellent article.... You are personally opting for surgery.....has surgery been recommended for you?

Aside....did you wife get a complete hip replacement or a partial? She walked on it for 4 weeks is amazing ...

Stratifying prostate cancer by risk
The NCCN guidelines stratify prostate cancer by risk. The risk groups are based on the staging of the prostate cancer, the Gleason score, PSA, and number and extent of biopsy cores positive for cancer. The risk stratification may help decide what treatment option is best for each individual.

Very low risk: Stage T1c, Gleason score < 6, PSA < 10 ng/dL, < 3 prostate biopsy cores positive for cancer, < 50% cancer in any core, PSA density < 0.15ng/ml/g.

Low risk: stage T1-T2a, Gleason score < 6, PSA < 10ng/mL

Intermediate risk: stage T2b-T2c, Gleason score 7 or PSA 10-20ng/mL

High risk: Stage T3a or Gleason score 8-10, PSA > 20ng/mL

Very high risk: Stage T3b-T4, primary Gleason patter 5 or > 4 cores with Gleason 8-10

medicinenet.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext